Video
Developing an active surveillance protocol for patients receiving a diagnosis of prostate cancer after HoLEP
Author(s):
Ashley E. Ross, MD, PhD, provides an overview of his institution’s new protocol for this subset of patients.
Video Player is loading.
In this video, Ashley E. Ross, MD, PhD, discusses an active surveillance protocol for patients undergoing holmium laser enucleation of the prostate for benign prostatic hyperplasia who subsequently receive a diagnosis of prostate cancer. Ross is an associate professor of urology at Northwestern University Feinberg School of Medicine in Chicago, Illinois.
Related Videos
Dr Louise Kostos on the rapidly evolving prostate cancer treatment landscape
An expert’s view on combination ARPI/ADT and long-term toxicity in prostate cancer
Perry Xu, MD, on the potential of AI in the endourology space
Rana McKay, MD, on the role of radium-223 in the modern era
Dr Louise Kostos discusses PSA kinetics in mHSPC
The importance of PSADT in high-risk, biochemically recurrent prostate cancer
Neeraj Agarwal, MD, outlines data on enzalutamide plus talazoparib in mCRPC
Expert discusses triplet regimens in metastatic hormone-sensitive prostate cancer
Amy E. Krambeck, MD, on what’s needed to improve safety, efficacy of HoLEP
Alicia Morgans, MD, MPH, on PSADT awareness and prostate cancer treatment initiation
Related Content
